The clinically inapparent adrenal mass: Update in diagnosis and management

Endocrine Reviews

Volumn 25, Issue 2, 2004, Pages 309-340

  Mansmann, Georg ^a   Lau, Joseph ^b   Balk, Ethan ^b   Rothberg, Michael ^c   Miyachi, Yukitaka ^d   Bornstein, Stefan R ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b TUFTS MEDICAL CENTER   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

^d TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; CLONIDINE; CORTICOTROPIN; DEXAMETHASONE; GLUCAGON; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID; MOLECULAR MARKER; POTASSIUM SPARING DIURETIC AGENT; SEX HORMONE; SPIRONOLACTONE; TUMOR MARKER;

ADRENAL CORTEX CARCINOMA; ADRENAL GLAND; ADRENAL TUMOR; ADRENALECTOMY; ASPIRATION BIOPSY; BENIGN TUMOR; BIOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DIAGNOSTIC ACCURACY; ENDOCRINE FUNCTION TEST; ENDOCRINE SYSTEM; EVALUATION; FOLLOW UP; GYNECOMASTIA; HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; IMAGING; IMAGING SYSTEM; IMPOTENCE; INCIDENTAL FINDING; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; MEDLINE; METASTASIS; MYELOLIPOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; RADIOLOGICAL PARAMETERS; REVIEW; SCINTIGRAPHY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TUMOR VOLUME; ULTRASOUND;

ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ADRENALECTOMY; ALDOSTERONE; BIOPSY, FINE-NEEDLE; DIAGNOSTIC IMAGING; GONADAL STEROID HORMONES; HORMONES; HUMANS; HYDROCORTISONE; MEDLINE; NEOPLASM METASTASIS; PHEOCHROMOCYTOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 1942436088     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2002-0031     Document Type: Review

References (474)

1. Geelhoed GW, Druy EM 1982 Management of the adrenal "incidentaloma. " Surgery 92:866-874
2. Prinz RA, Brooks MH, Churchill R, Graner JL, Lawrence AM, Paloyan E, Sparagana M 1982 Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required? JAMA 248:701-704
3. Aron DC 2001 The adrenal incidentaloma: disease of modern technology and public health problem. Rev Endocr Metab Disord 2:335-342
4. Thompson GB, Young Jr WF 2003 Adrenal incidentaloma. Curr Opin Oncol 15:84-90
5. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B 1995 Incidentally discovered adrenal masses. Endocr Rev 16:460-484
6. Copeland PM 1983 The incidentally discovered adrenal mass. Ann Intern Med 98:940-945
7. Kievit J, Haak HR 2000 Diagnosis and treatment of adrenal incidentaloma. A cost-effectiveness analysis. Endocrinol Metab Clin North Am 29:69-90, 76iii-ix
8. Ross NS, Aron DC 1990 Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 323:1401-1405
9. Schteingart DE 2000 Management approaches to adrenal incidentalomas. A view from Ann Arbor, Michigan. Endocrinol Metab Clin North Am 29:127-139, ix-x
10. Young Jr WF 2000 Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29:159-185, x
11. Latronico AC, Chrousos GP 1997 Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab 82:1317-1324
12. Stratakis CA, Chrousos GP 2000 Adrenal cancer. Endocrinol Metab Clin North Am 29:15-25, vii-viii
13. Bornstein SR, Stratakis CA, Chrousos GP 1999 Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann Intern Med 130:759-771
14. Gicquel C, Bertherat J, Le Bouc Y, Bertagna X 2000 Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms. Endocrinol Metab Clin North Am 29:1-13, vii
15. Stowasser M, Gunasekera TG, Gordon RD 2001 Familial varieties of primary aldosteronism. Clin Exp Pharmacol Physiol 28:1087-1090
16. Stratakis CA 2001 Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes. J Endocrinol Invest 24:370-383
17. Lacroix A, Ndiaye N, Tremblay J, Hamet P 2001 Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22:75-110
18. Marx C, Ehrhart-Bornstein M, Scherbaum WA, Bornstein SR 1998 Regulation of adrenocortical function by cytokines-relevance for immune-endocrine interaction. Horm Metab Res 30:416-420
19. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS 2003 Management of the clinically inapparent adrenal mass ("incidentaloma") . Ann Intern Med 138: 424-429
20. Lau J, Balk E, Rothberg M, Ioannidis JPA, De Vine D, Chew P, Kupelnik B, Miller K 2002 Management of clinically inapparent adrenal mass. Evidence report/technology assessment no. 56. Prepared by New England Medical Center Evidence-based Practice Center under contract no. 290-97-0019, AHRQ pub. no. 02-E014. Rockville, MD: Agency for Healthcare Research and Quality.
21. Abecassis M, McLoughlin MJ, Langer B, Kudlow JE 1985 Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg 149:783-788
22. Commons RR, Callaway CP 1948 Adenomas of the adrenal cortex. Arch Intern Med 81:37-141
23. Russi S, Blumenthal HT, Gray SH 1945 Small adenomas of the adrenal cortex in hypertension and diabetes. Arch Intern Med 76:284-291
24. Kokko JP, Brown TC, Berman MM 1967 Adrenal adenoma and hypertension. Lancet 1:468-470
25. Hedeland H, Ostberg G, Hokfelt B 1968 On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184:211-214
26. Masumori N, Adachi H, Noda Y, Tsukamoto T 1998 Detection of adrenal and retroperitoneal masses in a general health examination system. Urology 52:572-576
27. Kluglich M, Duelli R, Zoller WG, Middeke M 1993 [Ultrasound of incidental rumors of the adrenal gland and endocrine hypertension]. Bildgebung 60:144-146
28. Belldegrun A, Hussain S, Seltzer SE, Loughlin KR, Gittes RF, Richie JP 1986 Incidentally discovered mass of the adrenal gland. Surg Gynecol Obstet 163:203-208
29. Caplan RH, Strutt PJ, Wickus GG 1994 Subclinical hormone secretion by incidentally discovered adrenal masses. Arch Surg 129: 291-296
30. Glazer HS, Weyman PJ, Sagel SS, Levitt RG, McClennan BL 1982 Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR Am J Roentgenol 139:81-85
31. Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM 1991 Incidentally discovered adrenal tumors: an institutional perspective. Surgery 110:1014-1021
32. Kley HK, Wagner H, Jaresch S, Jungblut R, Schlaghecke R 1990 Endokrin inaktive Nebennierentumoren. In: Allolio B, Schulte HM, eds. Moderne diagnostik und therapeutische strategien bei nebennierenerkrankungen. Stuttgart: Schattauer; 189-197
33. Gillams A, Roberts CM, Shaw P, Spiro SG, Goldstraw P 1992 The value of CT scanning and percutaneous fine needle aspiration of adrenal masses in biopsy-proven lung cancer. Clin Radiol 46:18-22
34. Pagani JJ, Bernardino ME 1982 Incidence and significance of serendipitous CT findings in the oncologic patient. J Comput Assist Tomogr 6:268-275
35. Guerrero LA 1985 Diagnostic and therapeutic approach to incidental adrenal mass. Urology 26:435-440
36. Bernardino ME, Walther MM, Phillips VM, Graham Jr SD, Sewell CW, Gedgaudas-McClees K, Baumgartner BR, Torres WE, Erwin BC 1985 CT-guided adrenal biopsy: accuracy, safety, and indications. AJR Am J Roentgenol 144:67-69
37. Hussain S, Belldegrun A, Seltzer SE, Richie JP, Abrams HL 1986 CT diagnosis of adrenal abnormalities in patients with primary non-adrenal malignancies. Eur J Radiol 6:127-131
38. Francis IR, Smid A, Gross MD, Shapiro B, Naylor B, Glazer GM 1988 Adrenal masses in oncologic patients: functional and morphologic evaluation. Radiology 166:353-356
39. Chang SY, Lee SS, Ma CP, Lee SK 1989 Non-functioning tumours of the adrenal cortex. Br J Urol 63:462-464
40. Virkkala A, Valimaki M, Pelkonen R, Huikuri K, Kahri A, Kivisaari L, Korhonen T, Salmi J, Seppala P 1989 Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography. Acta Endocrinol (Copenh) 121: 67-72
41. Gaboardi F, Carbone M, Bozzola A, Galli L 1991 Adrenal incidentalomas: what is the role of fine needle biopsy? Int Urol Nephrol 23:197-207
42. Caplan RH, Kisken WA, Huiras CM 1991 Incidentally discovered adrenal masses. Minn Med 74:23-26
43. Chapuis Y 1991 [Adrenal surgery in 1990]. Ann Chir 45:5-7
44. Aso Y, Homma Y 1992 A survey on incidental adrenal tumors in Japan. J Urol 147:1478-1481
45. Jockenhovel F, Kuck W, Hauffa B, Reinhardt W, Benker G, Lederbogen S, Olbricht T, Reinwein D 1992 Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas). J Endocrinol Invest 15:331-337
46. Turton DB, O'Brian JT, Shakir KM 1992 Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone. J Endocrinol Invest 15: 789-796
47. Corsello SM, Della Casa S, Bollanti L, Rufini V, Rota CA, Danza F, Colasanti S, Vellante C, Troncone L, Barbarino A 1993 Incidentally discovered adrenal masses: a functional and morphological study. Exp Clin Endocrinol 101:131-137
48. Kobayashi S, Seki T, Nonomura K, Gotoh T, Togashi M, Koyanagi T 1993 Clinical experience of incidentally discovered adrenal tumor with particular reference to cortical function. J Urol 150:8-12
49. Nakajo M, Nakabeppu Y, Yonekura R, Iwashita S, Goto T 1993 The role of adrenocortical scintigraphy in the evaluation of unilateral incidentally discovered adrenal and juxtaadrenal masses. Ann Nucl Med 7:157-166
50. Burt M, Heelan RT, Coit D, McCormack PM, Bains MS, Martini N, Rusch V, Ginsberg RJ 1994 Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging. J Thorac Cardiovasc Surg 107:584-588; discussion 588-589
51. Boland GW, Goldberg MA, Lee MJ, Mayo-Smith WW, Dixon J, McNicholas MM, Mueller PR 1995 Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 194:131-134
52. Flecchia D, Mazza E, Carlini M, Blatto A, Olivieri F, Serra G, Camanni F, Messina M 1995 Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin Endocrinol (Oxf) 42:129-134
53. Ambrosi B, Peverelli S, Passini E, Re T, Ferrario R, Colombo P, Sartorio A, Faglia G 1995 Abnormalities of endocrine function in patients with clinically "silent" adrenal masses. Eur J Endocrinol 132:422-428
54. Bencsik Z, Szabolcs I, Goth M, Voros A, Kaszas I, Gonczi J, Kovacs L, Dohan O, Szilagyi G 1995 Incidentally detected adrenal tumours (incidentalomas): histological heterogeneity and differentiated therapeutic approach. J Intern Med 237:585-589
55. Terzolo M, Osella G, Ali A, Reimondo G, Borretta G, Magro GP, Luceri S, Paccotti P, Angeli A 1995 Adrenal incidentaloma, a five year experience. Minerva Endocrinol 20:69-78
56. Aydintug S, Kocak S, Eraslan S 1996 Primary non-functioning tumours of the adrenal cortex: an eight-year experience in Turkey. Eur J Surg 162:275-278
57. Bastounis EA, Karayiannakis AJ, Anapliotou ML, Nakopoulou L, Makri GG, Papalambros EL 1997 Incidentalomas of the adrenal gland: diagnostic and therapeutic implications. Am Surg 63:356-360
58. Bondanelli M, Campo M, Trasforini G, Ambrosio MR, Zatelli MC, Franceschetti P, Valentini A, Pansini R, degli Uberti EC 1997 Evaluation of hormonal function in a series of incidentally discovered adrenal masses. Metabolism 46:107-113
59. Mantero F, Masini AM, Opocher G, Giovagnetti M, Arnaldi G 1997 Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. Horm Res 47:284-289
60. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A 2000 A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637-644
61. Kasperlik-Zeluska AA, Roslonowska E, Slowinska-Srzednicka J, Migdalska B, Jeske W, Makowska A, Snochowska H 1997 Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) 46:29-37
62. Barzon L, Scaroni C, Sonino N, Fallo F, Gregianin M, Macri C, Boscaro M 1998 Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J Clin Endocrinol Metab 83:55-62
63. Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB, Ilstrup DM 1998 Can adrenal incidentalomas be safely observed? World J Surg 22:599-603; discussion 603-604
64. Xiao XR, Ye LY, Shi LX, Cheng GF, Li YT, Zhou BM 1998 Diagnosis and treatment of adrenal tumours: a review of 35 years' experience. Br J Urol 82:199-205
65. Tutuncu NB, Gedik O 1999 Adrenal incidentaloma: report of 33 cases. J Surg Oncol 70:247-250
66. Fontana D, Porpiglia F, Destefanis P, Fiori C, Ali A, Terzolo M, Osella G, Angeli A 1999 What is the role of ultrasonography in the follow-up of adrenal incidentalomas? The Gruppo Piemontese Incidentalomi Surrenalici. Urology 54:612-616
67. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G 2000 Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85:1440-1448
68. Luton JP, Martinez M, Coste J, Bertherat J 2000 Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center. Eur J Endocrinol 143:111-117
69. Hashimoto S, Midorikawa S, Sanada H, Watanabe T 2000 SSPG titer is a diagnostic marker for adrenocortical adenoma in patients with non-functioning adrenal incidentaloma. Biomed Pharmacother 54(Suppl 1):175S-177S
70. Seppel T, Schlaghecke R 1996 [Subclinical hypercortisolism in incidentally detected adrenal adenoma]. Dtsch Med Wochenschr 121:503-507; discussion 508
71. Bülow B, Ahren B 2002 Adrenal incidentaloma-experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 252:239-246
72. Andreis M, Avataneo T 1985 [Computed tomography of non-functioning adrenal masses]. Radiol Med (Torino) 71:206-210
73. Pfister B, Henry JF, Conte-Devolx B, Lantieri O, Codaccioni JL 1987 [Adrenal tumors of fortuitous discovery. 13 cases]. Presse Med 16:1075-1078
74. Osella G, Terzolo M, Borretta G, Magro G, Ali A, Piovesan A, Paccotti P, Angeli A 1994 Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). J Clin Endocrinol Metab 79:1532-1539
75. Vierhapper H, Heinze G, Gessl A, Exner M 2003 Adrenocortical tumors: prevalence of impaired glucose tolerance and of "Paradoxical Rise" of cortisol during an oral glucose tolerance test. Exp Clin Endocrinol Diabetes 111:415-420
76. Kjellman M, Larsson C, Backdahl M 2001 Genetic background of adrenocortical tumor development. World J Surg 25:948-956
77. Granger P, Genest J 1970 Autopsy study of adrenals in unselected normotensive and hypertensive patients. Can Med Assoc J 103: 34-36
78. Russell RP, Masi AT, Richter ED 1972 Adrenal cortical adenomas and hypertension. A clinical pathologic analysis of 690 cases with matched controls and a review of the literature. Medicine (Baltimore) 51:211-225
79. Jaresch S, Kornely E, Kley HK, Schlaghecke R 1992 Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab 74:685-689
80. Adams JE, Johnson RJ, Rickards D, Isherwood I 1983 Computed tomography in adrenal disease. Clin Radiol 34:39-49
81. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W 1992 Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 75:826-832
82. Tanabe A, Naruse M, Nishikawa T, Yoshimoto T, Shimizu T, Seki T, Takagi S, Imaki T, Takano K 2001 Autonomy of cortisol secretion in clinically silent adrenal incidentaloma. Horm Metab Res 33:444-450
83. Terzolo M, Osella G, Ali A, Borretta G, Cesario F, Paccotti P, Angeli A 1998 Subclinical Cushing's syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf) 48:89-97
84. Valli N, Catargi B, Ronci N, Vergnot V, Leccia F, Fernere JM, Chene G, Grenier N, Laurent F, Tabarin A 2001 Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Eur J Endocrinol 144:401-408
85. Bernini G, Moretti A, Argenio G, Salvetti A 2002 Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur J Endocrinol 146:523-529
86. Bravo EL 2002 Pheochromocytoma. Cardiol Rev 10:44-50
87. Young Jr WF 1997 Pheochromocytoma: issues in diagnosis, treatment. Compr Ther 23:319-326
88. Sutton MG, Sheps SG, Lie JT 1981 Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 56:354-360
89. Anderson Jr GH, Blakeman N, Streeten DH 1994 The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 12:609-615
90. Wilhelmsen L, Berglund G 1977 Prevalence of primary and secondary hypertension. Am Heart J 94:543-546
91. Mannelli M, Ianni L, Cilotti A, Conti A 1999 Pheochromocytoma in Italy: a multicentric retrospective study. Eur J Endocrinol 141: 619-624
92. Remine WH, Chong GC, Van Heerden JA, Sheps SG, Harrison Jr EG 1974 Current management of pheochromocytoma. Ann Surg 179:740-748
93. Whalen RK, Althausen AF, Daniels GH 1992 Extra-adrenal pheochromocytoma. J Urol 147:1-10
94. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS 2001 Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 134:315-329
95. 1975 Third national cancer survey: incidence data. Natl Cancer Inst Monogr: i-x, 1-454
96. Hutter Jr AM, Kayhoe DE 1966 Adrenal cortical carcinoma. Clinical features of 138 patients. Am J Med 41:572-580
97. Nader S, Hickey RC, Sellin RV, Samaan NA 1983 Adrenal cortical carcinoma. A study of 77 cases. Cancer 52:707-711
98. Soreide JA, Brabrand K, Thoresen SO 1992 Adrenal cortical carcinoma in Norway, 1970-1984. World J Surg 16:663-667; discussion 668
99. Ng L, Libertino JM 2003 Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169:5-11
100. Wooten MD, King DK 1993 Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72:3145-3155
101. Crucitti F, Bellantone R, Ferrante A, Boscherini M, Crucitti P 1996 The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. Surgery 119:161-170
102. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, Latronico AC, Campos Carneiro P, Alves VA, Zerbini MC, Liberman B, Carlos Gomes G, Kirschner MA 2000 Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88:711-736
103. Del Gaudio AD, Del Gaudio GA 1993 Virilizing adrenocortical tumors in adult women. Report of 10 patients, 2 of whom each had a tumor secreting only testosterone. Cancer 72:1997-2003
104. Patil KK, Ransley PG, McCullagh M, Malone M, Spitz L 2002 Functioning adrenocortical neoplasms in children. BJU Int 89:562-565
105. Weingartner K, Gerharz EW, Bittinger A, Rosai J, Leppek R, Riedmiller H 1995 Isolated clinical syndrome of primary aldosteronism in a patient with adrenocortical carcinoma. Case report and review of the literature. Urol Int 55:232-235
106. Barzon L, Fallo F, Sonino N, Daniele O, Boscaro M 1997 Adrenocortical carcinoma: experience in 45 patients. Oncology 54:490-496
107. Boscaro M, Fallo F, Barzon L, Daniele O, Sonino N 1995 Adrenocortical carcinoma: epidemiology and natural history. Minerva Endocrinol 20:89-94
108. Didolkar MS, Bescher RA, Elias EG, Moore RH 1981 Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer 47:2153-2161
109. Grondal S, Cedermark B, Eriksson B, Grimelius L, Harach R, Kristoffersson A, Rastad J, Uden P, Akerstrom G 1990 Adrenocortical carcinoma. A retrospective study of a rare tumor with a poor prognosis. Eur J Surg Oncol 16:500-506
110. Icard P, Chapuis Y, Andreassian B, Bernard A, Proye C 1992 Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 112:972-979; discussion 979-980
111. Kasperlik-Zaluska AA, Migdalska BM, Zgliczynski S, Makowska AM 1995 Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer 75:2587-2591
112. Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X, Laudat MH, Louvel A, Chapuis Y, Blondeau P, Bonnin A, Bricaire H 1990 Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322:1195-1201
113. Nakano M 1988 Adrenal cortical carcinoma. A clinicopathological and immunohistochemical study of 91 autopsy cases. Acta Pathol Jpn 38:163-180
114. Pommier RF, Brennan MF 1992 An eleven-year experience with adrenocortical carcinoma. Surgery 112:963-970; discussion 970-971
115. Tritos NA, Cushing GW, Heatley G, Libertino JA 2000 Clinical features and prognostic factors associated with adrenocortical carcinoma: Lahey Clinic Medical Center experience. Am Surg 66:73-79
116. Venkatesh S, Hickey RC, Sellin RV, Fernandez JF, Samaan NA 1989 Adrenal cortical carcinoma. Cancer 64:765-769
117. Favia G, Lumachi F, D'Amico DF 2001 Adrenocortical carcinoma: is prognosis different in nonfunctioning tumors? Results of surgical treatment in 31 patients. World J Surg 25:735-738
118. Henley DJ, van Heerden JA, Grant CS, Carney JA, Carpenter PC 1983 Adrenal cortical carcinoma - a continuing challenge. Surgery 94:926-931
119. Hogan TF, Gilchrist KW, Westring DW, Citrin DL 1980 A clinical and pathological study of adrenocortical carcinoma: therapeutic implications. Cancer 45:2880-2883
120. Vassilopoulou-Sellin R, Schultz PN 2001 Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer 92:1113-1121
121. Lam KY, Lo CY 2002 Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol (Oxf) 56:95-101
122. Abrams HL, Siro R, Goldstein N 1950 Metastases in carcinoma: analysis of 1,000 autopsied cases. Cancer 3:74-85
123. Lumb G, Mackenzie DH 1959 The incidence of metastases in adrenal glands and ovaries removed for carcinoma of the breast. Cancer 12:521-526
124. Lenert JT, Barnett Jr CC, Kudelka AP, Sellin RV, Gagel RF, Prieto VG, Skibber JM, Ross MI, Pisters PW, Curley SA, Evans DB, Lee JE 2001 Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery 130: 1060-1067
125. Han M, Burnett AL, Fishman EK, Marshall FF 1997 The natural history and treatment of adrenal myelolipoma. J Urol 157:1213-1216
126. Yildiz L, Akpolat I, Erzurumlu K, Aydin O, Kandemir B 2000 Giant adrenal myelolipoma: case report and review of the literature. Pathol Int 50:502-504
127. Chen CL, Huang ST, Chang PL, Ng KF 2000 Adrenal ganglioneuroma: report of five cases. Changgeng Yi Xue Za Zhi 23:550-554
128. Bellantone R, Ferrante A, Raffaelli M, Boscherini M, Lombardi CP, Crucitti F 1998 Adrenal cystic lesions: report of 12 surgically treated cases and review of the literature. J Endocrinol Invest 21: 109-114
129. Wenig BM, Abbondanzo SL, Heffess CS 1994 Epithelioid angiosarcoma of the adrenal glands. A clinicopathologic study of nine cases with a discussion of the implications of finding "epithelial-specific" markers. Am J Surg Pathol 18:62-73
130. Wang J, Sun NC, Renslo R, Chuang CC, Tabbarah HJ, Barajas L, French SW 1998 Clinically silent primary adrenal lymphoma: a case report and review of the literature. Am J Hematol 58:130-136
131. Mermershtain W, Liel Y, Zirkin HJ, Lupu L, Lantsberg S, Cohen Y 2001 Primary bilateral adrenal lymphoma relapsing as a solid cerebral mass after complete clinical remission: a case report. Am J Clin Oncol 24:583-585
132. Baker ME, Spritzer C, Blinder R, Herfkens RJ, Leight GS, Dunnick NR 1987 Benign adrenal lesions mimicking malignancy on MR imaging: report of two cases. Radiology 163:669-671
133. Lio S, Cibin M, Marcello R, Viviani MA, Ajello L 2000 Adrenal bilateral incidentaloma by reactivated histoplasmosis. J Endocrinol Invest 23:476-479
134. Lam KY, Lo CY 1999 Composite pheochromocytoma-ganglioneuroma of the adrenal gland: an uncommon entity with distinctive clinicopathologic features. Endocr Pathol 10:343-352
135. Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA 1991 Ultrastructural evidence for cortico-chromaffin hybrid cells in rat adrenals? Endocrinology 129:1113-1115
136. Miettinen M 1992 Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy. Lab Invest 66:169-174
137. Stratakis CA, Carney JA, Kirschner LS, Willenberg HS, Brauer S, Ehrhart-Bornstein M, Bornstein SR 1999 Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex. J Clin Endocrinol Metab 84:1122-1128
138. Calhoun SK, Murphy RC, Shariati N, Jacir N, Bergman K 2001 Extramedullary hematopoiesis in a child with hereditary spherocytosis: an uncommon cause of an adrenal mass. Pediatr Radiol 31:879-881
139. Boscaro M, Barzon L, Fallo F, Sonino N 2001 Cushing's syndrome. Lancet 357:783-791
140. Bravo EL 1994 Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15:356-368
141. Bravo EL 1994 Primary aldosteronism. Issues in diagnosis and management. Endocrinol Metab Clin North Am 23:271-283
142. Findling JW, Raff H 2001 Diagnosis and differential diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 30:729-747
143. Flack MR, Oldfield EH, Cutler Jr GB, Zweig MH, Malley JD, Chrousos GP, Loriaux DL, Nieman LK 1992 Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med 116:211-217
144. Meier CA, Biller BM 1997 Clinical and biochemical evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am 26:741-762
145. Newell-Price J, Grossman A 2002 Biochemical and imaging evaluation of Cushing's syndrome. Minerva Endocrinol 27:95-118
146. Nieman LK 1997 Cushing's syndrome. Curr Ther Endocrinol Metab 6:161-164
147. Torpy DJ, Stratakis CA, Chrousos GP 1999 Hyper-and hypoaldosteronism. Vitam Horm 57:177-216
148. Tsigos C, Chrousos GP 1996 Differential diagnosis and management of Cushing's syndrome. Annu Rev Med 47:443-461
149. Young Jr WF, Hogan MJ, Wee GG, Grant CS, van Heerden JA 1990 Primary aldosteronism: diagnosis and treatment. Mayo Clin Proc 65:96-110
150. Barzon L, Boscaro M 2000 Diagnosis and management of adrenal incidentalomas. J Urol 163:398-407
151. Barzon L, Fallo F, Sonino N, Boscaro M 2002 Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 146:61-66
152. Terzolo M, Pia A, Ali A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A 2002 Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87:998-1003
153. Reincke M 2000 Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29:43-56
154. Ross NS 1994 Epidemiology of Cushing's syndrome and subclinical disease. Endocrinol Metab Clin North Am 23:539-546
155. Crapo L 1979 Cushing's syndrome: a review of diagnostic tests. Metabolism 28:955-977
156. Aron DC, Tyrrell JB, Fitzgerald PA, Findling JW, Forsham PH 1981 Cushing's syndrome: problems in diagnosis. Medicine (Baltimore) 60:25-35
157. Raff H, Raff JL, Findling JW 1998 Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab 83:2681-2686
158. Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N 1998 The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clin Endocrinol (Oxf) 48:627-633
159. Terzolo M, Osella G, Ali A, Borretta G, Magro GP, Termine A, Paccotti P, Angeli A 1996 Different patterns of steroid secretion in patients with adrenal incidentaloma. J Clin Endocrinol Metab 81: 740-744
160. Charbonnel B, Chatal JF, Ozanne P 1981 Does the corticoadrenal adenoma with "pre-Cushing's syndrome" exist? J Nucl Med 22: 1059-1061
161. Garrapa GG, Pantanetti P, Arnaldi G, Mantero F, Faloia E 2001 Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J Clin Endocrinol Metab 86:5301-5306
162. Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T 2001 The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf) 54:797-804
163. Tauchmanova L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S, Lombardi G 2002 Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 87:4872-4878
164. Fernandez-Real JM, Engel WR, Simo R, Salinas I, Webb SM 1998 Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma. Clin Endocrinol (Oxf) 49:53-61
165. Francucci CM, Pantanetti P, Garrapa GG, Massi F, Arnaldi G, Mantero F 2002 Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma. Clin Endocrinol (Oxf) 57:587-593
166. Bardet S, Rohmer V, Boux de Casson F, Coffin C, Ronci N, Sabatier JP, Lecomte P, Audran M, Henry-Amar M, Tabarin A 2002 [Bone mineral density and biological markers of bone repair in patients with adrenal incidentaloma: effect of subclinical hypercortisolism]. Rev Med Interne 23:508-517
167. Chiodini I, Torlontano M, Carnevale V, Guglielmi G, Cammisa M, Trischitta V, Scillitani A 2001 Bone loss rate in adrenal incidentalomas: a longitudinal study. J Clin Endocrinol Metab 86:5337-5341
168. Sartorio A, Conti A, Ferrero S, Giambona S, Re T, Passini E, Ambrosi B 1998 Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma. Eur J Endocrinol 138: 146-152
169. Tauchmanova L, Rossi R, Nuzzo V, del Puente A, Esposito-del Puente A, Pizzi C, Fonderico F, Lupoli G, Lombardi G 2001 Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. Eur J Endocrinol 145:241-247
170. Torlontano M, Chiodini I, Pileri M, Guglielmi G, Cammisa M, Modoni S, Carnevale V, Trischitta V, Scillitani A 1999 Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab 84:2381-2385
171. Hadjidakis D, Tsagarakis S, Roboti C, Sfakianakis M, Iconomidou V, Raptis SA, Thalassinos N 2003 Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas? Clin Endocrinol (Oxf) 58:72-77
172. Osella G, Reimondo G, Peretti P, Ali A, Paccotti P, Angeli A, Terzolo M 2001 The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis. J Clin Endocrinol Metab 86:604-607
173. Bernini G, Moretti A, Iacconi P, Miccoli P, Nami R, Lucani B, Salvetti A 2003 Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 148:213-219
174. Murai M, Baba S, Nakashima J, Tachibana M 1999 Management of incidentally discovered adrenal masses. World J Urol 17:9-14
175. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM 1992 A chimaeric 11 β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262-265
176. Litchfield WR, New MI, Coolidge C, Lifton RP, Dluhy RG 1997 Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid- remediable aldosteronism. J Clin Endocrinol Metab 82:3570-3573
177. Stowasser M 2001 Primary aldosteronism: revival of a syndrome. J Hypertens 19:363-366
178. Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, Smithers BM 2003 High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens 21:2149-2157
179. McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S 1991 Diagnosis under random conditions of all disorders of the renin-angiotensin- aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 73:952-957
180. Weinberger MH, Fineberg NS 1993 The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med 153:2125-2129
181. Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N, Slater GJ 2001 Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2:156-169
182. Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh TT, Hiremagalur B, Ellingson T, Duddempudi S, Eijsbouts A, Lenders JW 1998 Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab 83:2175-2185
183. Eisenhofer G, Walther M, Keiser HR, Lenders JW, Friberg P, Pacak K 2000 Plasma metanephrines: a novel and cost-effective test for pheochromocytoma. Braz J Med Biol Res 33:1157-1169
184. Eisenhofer G, Walther MM, Huynh TT, Li ST, Bornstein SR, Vortmeyer A, Mannelli M, Goldstein DS, Linehan WM, Lenders JW, Pacak K 2001 Pheochromocytomas
185. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G 2002 Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287:1427-1434
186. Sjoberg RJ, Simcic KJ, Kidd GS 1992 The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls. Arch Intern Med 152:1193-1197
187. Keiser HR 2001 Pheochromocytoma and related tumors. In: DeGroot LJ, Jameson JB, eds. Endocrinology. 4th ed. Philadelphia: W. B. Saunders Company; 1862-1883
188. d'Herbomez M, Gouze V, Huglo D, Nocaudie M, Pattou F, Proye C, Wemeau JL, Marchandise X 2001 Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma. J Nucl Med 42:993-997
189. Hsiao RJ, Parmer RJ, Takiyyuddin MA, O'Connor DT 1991 Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine (Baltimore) 70:33-45
190. Cordera F, Grant C, Van Heerden J, Thompson G, Young W 2003 Androgen-secreting adrenal tumors. Surgery 134:874-880
191. Terzolo M, Ali A, Osella G, Reimondo G, Pia A, Peretti P, Paccotti P, Angeli A 2000 The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. Eur J Endocrinol 142:611-617
192. Bencsik Z, Szabolcs I, Kovacs Z, Ferencz A, Voros A, Kaszas I, Bor K, Gonczi J, Goth M, Kovacs L, Dohan O, Szilagyi G 1996 Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors. J Clin Endocrinol Metab 81:1726-1729
193. Bernini GP, Argenio GF, Vivaldi MS, Moretti A, Miccoli P, Iacconi P, Magagna A, Salvetti A 1998 Utility of plasma dehydroepiandrosterone sulphate determination in adrenal incidentalomas. J Endocrinol Invest 21:365-371
194. Morio H, Terano T, Yamamoto K, Tomizuka T, Oeda T, Saito Y, Tamura Y, Sasano H 1996 Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor. Endocr J 43:387-396
195. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR 1998 Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171:201-204
196. Dunnick NR, Korobkin M 2002 Imaging of adrenal incidentalomas: current status. AJR Am J Roentgenol 179:559-568
197. Korobkin M 2000 CT characterization of adrenal masses: the time has come. Radiology 217:629-632
198. Mayo-Smith WW, Boland GW, Noto RB, Lee MJ 2001 State-of-the-art adrenal imaging. Radiographics 21:995-1012
199. Peppercorn PD, Grossman AB, Reznek RH 1998 Imaging of incidentally discovered adrenal masses. Clin Endocrinol (Oxf) 48: 379-388
200. Udelsman R, Fishman EK 2000 Radiology of the adrenal. Endocrinol Metab Clin North Am 29:27-42, viii
201. Mitnick JS, Bosniak MA, Megibow AJ, Naidich DP 1983 Non-functioning adrenal adenomas discovered incidentally on computed tomography. Radiology 148:495-499
202. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M 1999 Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 84:520-526
203. Lee MJ, Hahn PF, Papanicolaou N, Egglin TK, Saini S, Mueller PR, Simeone JF 1991 Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179:415-418
204. Szolar DH, Kammerhuber F 1997 Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? Radiology 202:517-521
205. Singer AA, Obuchowski NA, Einstein DM, Paushter DM 1994 Metastasis or adenoma? Computed tomographic evaluation of the adrenal mass. Cleve Clin J Med 61:200-205
206. McNicholas MM, Lee MJ, Mayo-Smith WW, Hahn PF, Boland GW, Mueller PR 1995 An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR Am J Roentgenol 165:1453-1459
207. van Erkel AR, van Gils AP, Lequin M, Kruitwagen C, Bloem JL, Falke TH 1994 CT and MR distinction of adenomas and nonadenomas of the adrenal gland. J Comput Assist Tomogr 18:432-438
208. Korobkin M, Brodeur FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR, Kazerooni EA 1996 Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 166:531-536
209. Korobkin M, Giordano T, Brodeur F, Francis IR, Siegelman ES, Quint LE, Dunnick NR, Heiken JP, Wang HH 1996 Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200:743-747
210. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Goodsitt M 1996 Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 200:737-742
211. Szolar DH, Kammerhuber FH 1998 Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology 207:369-375
212. Boland GW, Hahn PF, Pena C, Mueller PR 1997 Adrenal masses: characterization with delayed contrast-enhanced CT. Radiology 202:693-696
213. Cirillo Jr RL, Bennett WF, Vitellas KM, Poulos AG, Bova JG 1998 Pathology of the adrenal gland: imaging features. AJR Am J Roentgenol 170:429-435
214. Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR 2000 Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175:1411-1415
215. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR 2000 Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217: 798-802
216. Kebapci M, Kaya T, Gurbuz E, Adapinar B, Kebapci N, Demirustu C 2003 Differentiation of adrenal adenomas (lipid rich and lipid poor) from nonadenomas by use of washout characteristics on delayed enhanced CT. Abdom Imaging 28:709-715
217. Korobkin M, Brodeur F, Francis I, Quint L, Dunnick N, Londy F 1998 CT time-attenuation washout curves of adrenal adenomas and nonadenomas. Am J Roentgenol 170:747-752
218. Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR, Raghupathi KI 2002 Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222: 629-633
219. Krestin GP, Freidmann G, Fishbach R, Neufang KF, Allolio B 1991 Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs. CT. J Comput Assist Tomogr 15:104-110
220. Fishman EK, Deutch BM, Hartman DS, Goldman SM, Zerhouni EA, Siegelman SS 1987 Primary adrenocortical carcinoma: CT evaluation with clinical correlation. AJR Am J Roentgenol 148:531-535
221. Hussain S, Belldegrun A, Seltzer SE, Richie JP, Gittes RF, Abrams HL 1985 Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography. AJR Am J Roentgenol 144:61-65
222. Francis IR, Korobkin M 1996 Pheochromocytoma. Radiol Clin North Am 34:1101-1112
223. Welch TJ, Sheedy 2nd PF, van Heerden JA, Sheps SG, Hattery RR, Stephens DH 1983 Pheochromocytoma: value of computed tomography. Radiology 148:501-503
224. Velchik MG, Alavi A, Kressel HY, Engelman K 1989 Localization of pheochromocytoma: MIGB, CT, and MRI correlation. J Nucl Med 30:328-336
225. Kenney PJ, Wagner BJ, Rao P, Heffess CS 1998 Myelolipoma: CT and pathologic features. Radiology 208:87-95
226. Otal P, Escourrou G, Mazerolles C, Janne d'Othee B, Mezghani S, Musso S, Colombier D, Rousseau H, Joffre F 1999 Imaging features of uncommon adrenal masses with histopathologic correlation. Radiographics 19:569-581
227. Rao P, Kenney PJ, Wagner BJ, Davidson AJ 1997 Imaging and pathologic features of myelolipoma. Radiographics 17:1373-1385
228. Cyran KM, Kenney PJ, Memel DS, Yacoub I 1996 Adrenal myelolipoma. AJR Am J Roentgenol 166:395-400
229. Chezmar JL, Robbins SM, Nelson RC, Steinberg HV, Torres WE, Bernardino ME 1988 Adrenal masses: characterization with T1-weighted MR imaging. Radiology 166:357-359
230. Reinig JW, Doppman JL, Dwyer AJ, Frank J 1986 MRI of indeterminate adrenal masses. AJR Am J Roentgenol 147:493-496
231. Tsushima Y 1994 Different lipid contents between aldosterone-producing and nonhyperfunctioning adrenocortical adenomas: in vivo measurement using chemical-shift magnetic resonance imaging. J Clin Endocrinol Metab 79:1759-1762
232. Hönigschnabl S, Gallo S, Niederle B, Prager G, Kaserer K, Lechner G, Heinz-Peer G 2002 How accurate is MR imaging in characterisation of adrenal masses: update of a long-term study. Eur J Radiol 41:113-122
233. Outwater EK, Siegelman ES, Huang AB, Birnbaum BA 1996 Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 200:749-752
234. Bilbey JH, McLoughlin RF, Kurkjian PS, Wilkins GE, Chan NH, Schmidt N, Singer J 1995 MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors. AJR Am J Roentgenol 164:637-642
235. Schwartz LH, Panicek DM, Doyle MV, Ginsberg MS, Herman SK, Koutcher JA, Brown KT, Getrajdman GI, Burt M 1997 Comparison of two algorithms and their associated charges when evaluating adrenal masses in patients with malignancies. AJR Am J Roentgenol 168:1575-1578
236. Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S 1995 Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR Am J Roentgenol 165:91-95
237. Krestin GP, Steinbrich W, Friedmann G 1989 Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 171:675-680
238. Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM 1992 Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 185:345-351
239. Tsushima Y, Ishizaka H, Matsumoto M 1993 Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology 186:705-709
240. Slapa RZ, Jakubowski W, Januszewicz A, Kasperlik-Zaluska AA, Dabrowska E, Fijuth J, Feltynowski T, Tarnawski R, Krolicki L 2000 Discriminatory power of MRI for differentiation of adrenal non-adenomas vs. adenomas evaluated by means of ROC analysis: can biopsy be obviated? Eur Radiol 10:95-104
241. Schwartz LH, Ginsberg MS, Burt ME, Brown KT, Getrajdman GI, Panicek DM 1998 MRI as an alternative to CT-guided biopsy of adrenal masses in patients with lung cancer. Ann Thorac Surg 65:193-197
242. Namimoto T, Yamashita Y, Mitsuzaki K, Nakayama Y, Makita O, Kadota M, Takahashi M 2001 Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas. Radiology 218:642-646
243. Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S 2003 Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR Am J Roentgenol 180:1649-1657
244. Yeh HC 1980 Sonography of the adrenal glands: normal glands and small masses. AJR Am J Roentgenol 135:1167-1177
245. Suzuki K, Fujita K, Ushiyama T, Mugiya S, Kageyama S, Ishikawa A 1995 Efficacy of an ultrasonic surgical system for laparoscopic adrenalectomy. J Urol 154:484-486
246. Abrams HL, Siegelman SS, Adams DF, Sanders R, Finberg HJ, Hessel SJ, McNeil BJ 1982 Computed tomography versus ultrasound of the adrenal gland: a prospective study. Radiology 143: 121-128
247. Paivansalo M, Merikanto J, Kallioinen M, McAnsh G 1988 Ultrasound in the detection of adrenal tumours. Eur J Radiol 8:183-187
248. Ghiatas AA, Chopra S, Schnitker JB 1996 Is sonographic flow imaging useful in the differential diagnosis of adrenal masses? Br J Radiol 69:1005-1008
249. Goerg C, Schwerk WB, Wolf M, Havemann K 1992 Adrenal masses in lung cancer: sonographic diagnosis and follow-up. Eur J Cancer 28A:1400-1403
250. Kann P, Hengstermann C, Heussel CP, Bittinger F, Engelbach M, Beyer J 1998 Endosonography of the adrenal glands: normal size-pathological findings. Exp Clin Endocrinol Diabetes 106:123-129
251. Gross MD, Rubello D, Shapiro B 2002 Is there a future for adrenal scintigraphy? Nucl Med Commun 23:197-202
252. Rubello D, Bui C, Casara D, Gross MD, Fig LM, Shapiro B 2002 Functional scintigraphy of the adrenal gland. Eur J Endocrinol 147:13-28
253. Carey JE, Thrall JH, Freitas JE, Beierwaltes WH 1979 Absorbed dose to the human adrenals from lodomethylnorcholesterol (I-131) "NP-59": concise communication. J Nucl Med 20:60-62
254. Kloos RT, Gross MD, Shapiro B, Francis IR, Korobkin M, Thompson NW 1997 Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6β-iodomethyl-norcholesterol scintigraphy. World J Surg 21:36-40
255. Lumachi F, Marzola MC, Zucchetta P, Tregnaghi A, Cecchin D, Favia G, Bui F 2003 Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI. Nucl Med Commun 24:683-688
256. Gross MD, Shapiro B, Francis IR, Glazer GM, Bree RL, Arcomano MA, Schteingart DE, McLeod MK, Sanfield JA, Thompson NW 1994 Scintigraphic evaluation of clinically silent adrenal masses. J Nucl Med 35:1145-1152
257. Gross MD, Shapiro B, Francis IR, Bree RL, Korobkin M, McLeod MK, Thompson NW, Sanfield JA 1995 Scintigraphy of incidentally discovered bilateral adrenal masses. Eur J Nucl Med 22:315-321
258. Dominguez-Gadea L, Diez L, Bas C, Crespo A 1994 Differential diagnosis of solid adrenal masses using adrenocortical scintigraphy. Clin Radiol 49:796-799
259. Barzon L, Zucchetta P, Boscaro M, Marzola MC, Bui F, Fallo F 2001 Scintigraphic patterns of adrenocortical carcinoma: morphofunctional correlates. Eur J Endocrinol 145:743-748
260. Maurea S, Klain M, Mainolfi C, Ziviello M, Salvatore M 2001 The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses. J Nucl Med 42:884-892
261. Bardet S, Rohmer V, Murat A, Guillemot C, Marechaud R, Chupin M, Lecomte P, Simon D, Delemer B, Schneebelli S, Beutter D, Jacquin V, Peltier P, Charbonnel B 1996 131I-6 β-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clin Endocrinol (Oxf) 44:587-596
262. La Cava G, Imperiale A, Olianti C, Gheri GR, Ladu C, Mannelli M, Pupi A 2003 SPECT semiquantitative analysis of adrenocortical (131)I-6 β iodomethyl-norcholesterol uptake to discriminate subclinical and preclinical functioning adrenal incidentaloma. J Nucl Med 44:1057-1064
263. Dominguez-Gadea L, Diez L, Piedrola-Maroto G, Crespo A 1996 Scintigraphic diagnosis of subclinical Cushing's syndrome in patients with adrenal incidentalomas. Nucl Med Commun 17:29-32
264. Mozley PD, Kim CK, Mohsin J, Jatlow A, Gosfield 3rd E, Alavi A 1994 The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma. J Nucl Med 35:1138-1144
265. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH 1985 Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 26:576-585
266. Zhu RS, Ma JX, Xu JQ 1988 Imaging of adrenal medulla with I-131-mIBG. Clinical experience in 208 cases. Chin Med J (Engl) 101:513-516
267. Tenenbaum F, Lumbroso J, Schlumberger M, Mure A, Plouin PF, Caillou B, Parmentier C 1995 Comparison of radiolabeled octreotide and meta- iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med 36:1-6
268. Miskulin J, Shulkin BL, Doherty GM, Sisson JC, Burney RE, Gauger PG 2003 Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? Surgery 134:918-922
269. Erasmus JJ, Patz Jr EF, McAdams HP, Murray JG, Herndon J, Coleman RE, Goodman PC 1997 Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 168: 1357-1360
270. Maurea S, Mainolfi C, Bazzicalupo L, Panico MR, Imparato C, Alfano B, Ziviello M, Salvatore M 1999 Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR Am J Roentgenol 173:25-29
271. Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A 2001 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42:1795-1799
272. Zubeldia J, Abou-Zied M, Nabi H 2000 Patterns of adrenal gland involvement from lung cancer shown by 18F-fluorodeoxyglucose positron emission tomography compared to computed tomography and magnetic resonance imaging. Clin Positron Imaging 3:166
273. Becherer A, Vierhapper H, Potzi C, Karanikas G, Kurtaran A, Schmaljohann J, Staudenherz A, Dudczak R, Kletter K 2001 FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm 16: 289-295
274. Bergstrom M, Juhlin C, Bonasera TA, Sundin A, Rastad J, Akerstrom G, Langstrom B 2000 PET imaging of adrenal cortical tumors with the 11β-hydroxylase tracer 11C-metomidate. J Nucl Med 41:275-282
275. Khan TS, Sundin A, Juhlin C, Langstrom B, Bergstrom M, Eriksson B 2003 11C-Metomidate PET imaging of adrenocortical cancer. Eur J Nucl Med Mol Imaging 30:403-410
276. Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST, Goldstein DS 2001 6-[18F]Fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 38:6-8
277. Arola J, Salmenkivi K, Liu J, Kahri AI, Heikkila P 2000 p53 and Ki67 in adrenocortical tumors. Endocr Res 26:861-865
278. Reincke M, Karl M, Travis WH, Mastorakos G, Allolio B, Linehan HM, Chrousos GP 1994 p53 Mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab 78:790-794
279. Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M, Plouin PF, Luton JP, Le Bouc Y 2001 Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res 61:6762-6767
280. Heppner C, Reincke M, Agarwal SK, Mora P, Allolio B, Burns AL, Spiegel AM, Marx SJ 1999 MEN1 gene analysis in sporadic adrenocortical neoplasms. J Clin Endocrinol Metab 84:216-219
281. Gicquel C, Bertagna X, Schneid H, Francillard-Leblond M, Luton JP, Girard F, Le Bouc Y 1994 Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J Clin Endocrinol Metab 78:1444-1453
282. Ilvesmaki V, Kahri AI, Miettinen PJ, Voutilainen R 1993 Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas. J Clin Endocrinol Metab 77:852-858
283. Bourcigaux N, Gaston V, Logie A, Bertagna X, Le Bouc Y, Gicquel C 2000 High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical rumors. J Clin Endocrinol Metab 85:322-330
284. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peczkowska M, Szmigielski C, Eng C; Freiburg-Warsaw-Columbus Pheochromocytoma Study Group 2002 Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459-1466
285. de Krijger RR, van der Harst E, van der Ham F, Stijnen T, Dinjens WN, Koper JW, Braining HA, Lamberts SW, Bosman FT 1999 Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas. J Pathol 188:51-55
286. Arnaldi G, Freddi S, Mancini T, Kola B, Mantero F 2000 Transforming growth factor β1: implications in adrenocortical tumorigenesis. Endocr Res 26:905-910
287. Orlando C, Gelmini S 2001 Telomerase in endocrine and endocrine-dependent tumors. J Steroid Biochem Mol Biol 78:201-214
288. Mannelli M, Gelmini S, Arnaldi G, Becherini L, Bemporad D, Crescioli C, Pazzagli M, Mantero F, Serio M, Orlando C 2000 Telomerase activity is significantly enhanced in malignant adrenocortical rumors in comparison to benign adrenocortical adenomas. J Clin Endocrinol Metab 85:468-470
289. Kubota Y, Nakada T, Sasagawa I, Yanai H, Itoh K 1998 Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 82:176-179
290. Held EL, Gal AA, DeRose PB, Cohen C 1997 Image cytometric nuclear DNA quantitation of paragangliomas in tissue sections. Prognostic significance. Anal Quant Cytol Histol 19:501-506
291. Tormey WP, Fitzgerald RJ, Thomas G, Kay EW, Leader MB 2000 Catecholamine secretion and ploidy in phaeochromocytoma. Int J Clin Pract 54:520-523
292. Sasano H, Shizawa S, Suzuki T, Takayama K, Fukaya T, Morohashi K, Nagura H 1995 Transcription factor adrenal 4 binding protein as a marker of adrenocortical malignancy. Hum Pathol 26:1154-1156
293. Moreno AM, Castilla-Guerra L, Martinez-Torres MC, Torres-Olivera F, Fernandez E, Galera-Davidson H 1999 Expression of neuropeptides and other neuroendocrine markers in human phaeochromocytomas. Neuropeptides 33:159-163
294. Bernini GP, Moretti A, Ferdeghini M, Ricci S, Letizia C, D'Erasmo E, Argenio GF, Salvetti A 2001 A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine rumours. Br J Cancer 84:636-642
295. Eriksson B, Arnberg H, Oberg K, Hellman U, Lundqvist G, Wernstedt C, Wilander E 1989 Chromogranins-new sensitive markers for neuroendocrine rumors. Acta Oncol 28:325-329
296. Murray SA, Davis K, Fishman LM, Bornstein SR 2000 α1 Connexin 43 gap junctions are decreased in human adrenocortical rumors. J Clin Endocrinol Metab 85:890-895
297. Salmenkivi K, Haglund C, Ristimaki A, Arola J, Heikkila P 2001 Increased expression of cyclooxygenase-2 in malignant pheochromocytomas. J Clin Endocrinol Metab 86:5615-5619
298. Grouzmann E, Gicquel C, Plouin PF, Schlumberger M, Comoy E, Bohuon C 1990 Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas. Cancer 66:1833-1835
299. Oishi S, Sato T 1988 Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma. Cancer 61:1167-1170
300. Terzolo M, Boccuzzi A, Bovio S, Cappia S, De Giuli P, Ali A, Paccotti P, Porpiglia F, Fontana D, Angeli A 2001 Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors. Urology 57:176-182
301. Wachenfeld C, Beuschlein F, Zwermann O, Mora P, Fassnacht M, Allolio B, Reincke M 2001 Discerning malignancy in adrenocortical tumors: are molecular markers useful? Eur J Endocrinol 145: 335-341
302. Brown HM, Komorowski RA, Wilson SD, Demeure MJ, Zhu YR 1999 Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: a positive correlation between MIB-1 staining and malignant tumor behavior. Cancer 86:1583-1589
303. Ohji H, Sasagawa I, Iciyanagi O, Suzuki Y, Nakada T 2001 Tumour angiogenesis and Ki-67 expression in phaeochromocytoma. BJU Int 87:381-385
304. Marx C, Wolkersdorfer GW, Brown JW, Scherbaum WA, Bornstein SR 1996 MHC class II expression-a new tool to assess dignity in adrenocortical tumors. J Clin Endocrinol Metab 81:4488-4491
305. Tartour E, Caillou B, Tenenbaum F, Schroder S, Luciani S, Talbot M, Schlumberger M 1993 Immunohistochemical study of adrenocortical carcinoma. Predictive value of the D11 monoclonal antibody. Cancer 72:3296-3303
306. Schroder S, Niendorf A, Achilles E, Dietel M, Padberg BC, Beisiegel U, Dralle H, Bressel M, Kloppel G 1990 Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11. Virchows Arch A Pathol Anat Histopathol 417:89-96
307. Komminoth P, Roth J, Schroder S, Saremaslani P, Heitz PU 1995 Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors. Lab Invest 72:424-431
308. Koch CA, Vortmeyer AO, Diallo R, Poremba C, Giordano TJ, Sanders D, Bornstein SR, Chrousos GP, Pacak K 2002 Survivin: a novel neuroendocrine marker for pheochromocytoma. Eur J Endocrinol 146:381-388
309. Salmenkivi K, Haglund C, Arola J, Heikkila P 2001 Increased expression of tenascin in pheochromocytomas correlates with malignancy. Am J Surg Pathol 25:1419-1423
310. Salmenkivi K, Arola J, Voutilainen R, Ilvesmaki V, Haglund C, Kahri AI, Heikkila P, Liu J 2001 Inhibin/activin βB-subunit expression in pheochromocytomas favors benign diagnosis. J Clin Endocrinol Metab 86:2231-2235
311. Wiedenmann B, Franke WW 1985 Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41:1017-1028
312. Weiss LM, Medeiros LJ, Vickery Jr AL 1989 Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol 13:202-206
313. Weiss LM 1984 Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8:163-169
314. Fuhrman SA, Lasky LC, Limas C 1982 Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663
315. Stojadinovic A, Ghossein RA, Hoos A, Nissan A, Marshall D, Dudas M, Cordon-Cardo C, Jaques DP, Brennan MF 2002 Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol 20:941-950
316. Manger WM, Gifford RW 1996 Clinical and experimental pheochromocytoma. 2nd ed. Cambridge, UK; Blackwell
317. Amberson JB, Vaughan Jr ED, Gray GF, Naus GJ 1987 Flow cytometric determination of nuclear DNA content in benign adrenal pheochromocytomas. Urology 30:102-104
318. Hosaka Y, Rainwater LM, Grant CS, Farrow GM, van Heerden JA, Lieber MM 1986 Pheochromocytoma: nuclear deoxyribonucleic acid patterns studied by flow cytometry. Surgery 100:1003-1010
319. Capella C, Riva C, Cornaggia M, Chiaravalli AM, Frigerio B, Solcia E 1988 Histopathology, cytology and cytochemistry of pheochromocytomas and paragangliomas including chemodectomas. Pathol Res Pract 183:176-187
320. Thompson LD 2002 Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26:551-566
321. Bernardino ME 1988 Management of the asymptomatic patient with a unilateral adrenal mass. Radiology 166:121-123
322. Berkman WA, Bernardino ME, Sewell CW, Price RB, Sones Jr PJ 1984 The computed tomography-guided adrenal biopsy. An alternative to surgery in adrenal mass diagnosis. Cancer 53:2098-2103
323. Heaston DK, Handel DB, Ashton PR, Korobkin M 1982 Narrow gauge needle aspiration of solid adrenal masses. AJR Am J Roentgenol 138:1143-1148
324. Montali G, Solbiati L, Bossi MC, De Pra L, Di Donna A, Ravetto C 1984 Sonographically guided fine-needle aspiration biopsy of adrenal masses. AJR Am J Roentgenol 143:1081-1084
325. Katz RL, Patel S, Mackay B, Zornoza J 1984 Fine needle aspiration cytology of the adrenal gland. Acta Cytol 28:269-282
326. Welch TJ, Sheedy 2nd PF, Stephens DH, Johnson CM, Swensen SJ 1994 Percutaneous adrenal biopsy: review of a 10-year experience. Radiology 193:341-344
327. Saeger W, Fassnacht M, Chita R, Prager G, Nies C, Lorenz K, Barlehner E, Simon D, Niederle B, Beuschlein F, Allolio B, Reincke M 2003 High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Hum Pathol 34:180-186
328. Silverman SG, Mueller PR, Pinkney LP, Koenker RM, Seltzer SE 1993 Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies. Radiology 187:715-718
329. de Agustin P, Lopez-Rios F, Alberti N, Perez-Barrios A 1999 Fine-needle aspiration biopsy of the adrenal glands: a ten-year experience. Diagn Cytopathol 21:92-97
330. Kane NM, Korobkin M, Francis IR, Quint LE, Cascade PN 1991 Percutaneous biopsy of left adrenal masses: prevalence of pancreatitis after anterior approach. AJR Am J Roentgenol 157:777-780
331. Karstrup S, Torp-Pedersen S, Nolsoe C, Horn T, Hegedus L 1991 Ultrasonically guided fine-needle biopsies from adrenal tumors. Scand J Urol Nephrol Suppl 137:31-34
332. Lumachi F, Borsato S, Brandes AA, Boccagni P, Tregnaghi A, Angelini F, Favia G 2001 Fine-needle aspiration cytology of adrenal masses in noncancer patients: clinicoradiologic and histologic correlations in functioning and nonfunctioning tumors. Cancer 93:323-329
333. Mody MK, Kazerooni EA, Korobkin M 1995 Percutaneous CT-guided biopsy of adrenal masses: immediate and delayed complications. J Comput Assist Tomogr 19:434-439
334. Saboorian MH, Katz RL, Charnsangavej C 1995 Fine needle aspiration cytology of primary and metastatic lesions of the adrenal gland. A series of 188 biopsies with radiologic correlation. Acta Cytol 39:843-851
335. Wu HH, Cramer HM, Kho J, Elsheikh TM 1998 Fine needle aspiration cytology of benign adrenal cortical nodules. A comparison of cytologic findings with those of primary and metastatic adrenal malignancies. Acta Cytol 42:1352-1358
336. Gagner M, Lacroix A, Prinz RA, Bolte E, Albala D, Potvin C, Hamet P, Kuchel O, Querin S, Pomp A 1993 Early experience with laparoscopic approach for adrenalectomy. Surgery 114:1120-1124; discussion 1124-1125
337. Guazzoni G, Montorsi F, Bocciardi A, Da Pozzo L, Rigatti P, Lanzi R, Pontiroli A 1995 Transperitoneal laparoscopic versus open adrenalectomy for benign hyperfunctioning adrenal tumors: a comparative study. J Urol 153:1597-1600
338. Lezoche E, Guerrieri M, Feliciotti F, Paganini AM, Perretta S, Baldarelli M, Bonjer J, Miccoli P 2002 Anterior, lateral, and posterior retroperitoneal approaches in endoscopic adrenalectomy. Surg Endosc 16:96-99
339. Terachi T, Matsuda T, Terai A, Ogawa O, Kakehi Y, Kawakita M, Shichiri Y, Mikami O, Takeuchi H, Okada Y, Yoshida O 1997 Transperitoneal laparoscopic adrenalectomy: experience in 100 patients. J Endourol 11:361-365
340. Valeri A, Borrelli A, Presenti L, Lucchese M, Manca G, Tonelli P, Bergamini C, Borrelli D, Palli M, Saieva C 2002 The influence of new technologies on laparoscopic adrenalectomy. Surg Endosc 16:1274-1279
341. Brunt LM, Molmenti EP, Kerbl K, Soper NJ, Stone AM, Clayman RV 1993 Retroperitoneal endoscopic adrenalectomy: an experimental study. Surg Laparosc Endosc 3:300-306
342. de Canniere L, Lorge F, Rosiere A, Joucken K, Michel LA 1995 From laparoscopic training on an animal model to retroperitoneoscopic or coelioscopic adrenal and renal surgery in human. Surg Endosc 9:699-701
343. Whittle DE, Schroeder D, Purchas SH, Sivakumaran P, Conaglen JV 1994 Laparoscopic retroperitoneal left adrenalectomy in a patient with Cushing's syndrome. Aust N Z J Surg 64:375-376
344. Gill IS, Soble JJ, Sung GT, Winfield HN, Bravo EL, Novick AC 1998 Needlescopic adrenalectomy-the initial series: comparison with conventional laparoscopic adrenalectomy. Urology 52:180-186
345. Chueh SC, Chen J, Chen SC, Liao CH, Lai MK 2002 Clipless laparoscopic adrenalectomy with needlescopic instruments. J Urol 167:39-42; discussion 42-43
346. Schulsinger DA, Sosa RE, Perlmutter AP, Vaughan Jr ED 1999 Acute and chronic interstitial cryotherapy of the adrenal as a treatment modality. World J Urol 17:59-64
347. Gill IS, Sung GT, Hsu TH, Meraney AM 2000 Robotic remote laparoscopic nephrectomy and adrenalectomy: the initial experience. J Urol 164:2082-2085
348. Young JA, Chapman 3rd WH, Kim VB, Albrecht RJ, Ng PC, Nifong LW, Chitwood Jr WR 2002 Robotic-assisted adrenalectomy for adrenal incidentaloma: case and review of the technique. Surg Laparosc Endosc Percutan Tech 12:126-130
349. Munver R, Del Pizzo JJ, Sosa RE 2003 Adrenal-preserving minimally invasive surgery: the role of laparoscopic partial adrenalectomy, cryosurgery, and radiofrequency ablation of the adrenal gland. Curr Urol Rep 4:87-92
350. Gill IS 2001 The case for laparoscopic adrenalectomy. J Urol 166: 429-436
351. Vaughan Jr ED 1999 Surgical options for open adrenalectomy. World J Urol 17:40-47
352. Malmaeus J, Markaes A, Oberg K, el-Sherief MA, Johansson H, Rastad J, Wilander E, Akerstrom G 1986 Adrenal gland surgery. Preoperative location of lesions, histologic findings and outcome of surgery. Acta Chir Scand 152:577-581
353. Favia G, Lumachi F, Scarpa V, D'Amico DF 1992 Adrenalectomy in primary aldosteronism: a long-term follow-up study in 52 patients. World J Surg 16:680-683; discussion 683-684
354. Proye CA, Huart JY, Cuvillier XD, Assez NM, Gambardella B, Carnaille BM 1993 Safety of the posterior approach in adrenal surgery: experience in 105 cases. Surgery 114:1126-1131
355. Weigel RJ, Wells SA, Gunnells JC, Leight GS 1994 Surgical treatment of primary hyperaldosteronism. Ann Surg 219:347-352
356. Fahey 3rd TJ, Reeve TS, Delbridge L 1994 Adrenalectomy: expanded indications for the extraperitoneal approach. Aust N Z J Surg 64:494-497
357. van Heerden JA, Young Jr WF, Grant CS, Carpenter PC 1995 Adrenal surgery for hypercortisolism-surgical aspects. Surgery 117:466-472
358. Nash PA, Leibovitch I, Donohue JP 1995 Adrenalectomy via the dorsal approach: a benchmark for laparoscopic adrenalectomy. J Urol 154:1652-1654
359. Sand J, Saaristo J, Nordback I, Auvinen O 1997 Posterior approach for adrenal surgery: experiences with 59 patients. Ann Chir Gynaecol 86:234-237
360. Kolomecki K, Pomorski L, Kuzdak K, Narebski J, Wichman R 1999 The surgical treatment of adrenal gland tumors-incidentaloma. Neoplasma 46:124-127
361. Russell CF, Hamberger B, van Heerden JA, Edis AJ, Ilstrup DM 1982 Adrenalectomy: anterior or posterior approach? Am J Surg 144:322-324
362. Bruining HA, Lamberts SW, Ong EG, van Seyen AJ 1984 Results of adrenalectomy with various surgical approaches in the treatment of different diseases of the adrenal glands. Surg Gynecol Obstet 158:367-369
363. Irvin 3rd GL, Fishman LM, Sher JA, Yeung LK, Irani H 1989 Pheochromocytoma. Lateral versus anterior operative approach. Ann Surg 209:774-778
364. Nagesser SK, Kievit J, Hermans J, Krans HM, van de Velde CJ 2000 The surgical approach to the adrenal gland: a comparison of the retroperitoneal and the transabdominal routes in 326 operations on 284 patients. Jpn J Clin Oncol 30:68-74
365. Takeda M, Go H, Imai T, Komeyama T 1994 Experience with 17 cases of laparoscopic adrenalectomy: use of ultrasonic aspirator and argon beam coagulator. J Urol 152:902-905
366. Rutherford JC, Gordon RD, Stowasser M, Tunny TJ, Klemm SA 1995 Laparoscopic adrenalectomy for adrenal rumours causing hypertension and for 'incidentalomas' of the adrenal on computerized tomography scanning. Clin Exp Pharmacol Physiol 22:490-492
367. Janetschek G, Altarac S, Finkenstedt G, Gasser R, Bartsch G 1996 Technique and results of laparoscopic adrenalectomy. Eur Urol 30:475-479
368. Marescaux J, Mutter D, Wheeler MH 1996 Laparoscopic right and left adrenalectomies. Surgical procedures. Surg Endosc 10:912-915
369. Walmsley D, McIntyre R, Sawers HA, Shaw JA, Webster J, Krukowski ZH, Sevan JS 1996 Laparoscopic trans-peritoneal adrenalectomy: a preliminary report of 14 adrenalectomies. Clin Endocrinol (Oxf) 45:141-145
370. Fernandez-Cruz L, Saenz A, Benarroch G, Astudillo E, Taura P, Sabater L 1996 Laparoscopic unilateral and bilateral adrenalectomy for Cushing's syndrome. Transperitoneal and retroperitoneal approaches. Ann Surg 224:727-734; discussion 734-736
371. de Canniere L, Michel L, Hamoir E, Hubens G, Meurisse M, Squifflet JP, Urban P, Vereecken L 1996 Videoendoscopic adrenalectomy: multicentric study from the Belgian Group for Endoscopic Surgery (BGES). Int Surg 81:6-8
372. Gagner M, Pomp A, Heniford BT, Pharand D, Lacroix A 1997 Laparoscopic adrenalectomy: lessons learned from 100 consecutive procedures. Ann Surg 226:238-246; discussion 246-247
373. Horgan S, Sinanan M, Helton WS, Pellegrini CA 1997 Use of laparoscopic techniques improves outcome from adrenalectomy. Am J Surg 173:371-374
374. Shichman SJ, Herndon CD, Sosa RE, Whalen GF, MacGillivray DC, Malchoff CD, Vaughan ED 1999 Lateral transperitoneal laparoscopic adrenalectomy. World J Urol 17:48-53
375. Pujol J, Viladrich M, Rafecas A, Llado L, Garcia-Barrasa A, Figueras J, Jaurrieta E 1999 Laparoscopic adrenalectomy. A review of 30 initial cases. Surg Endosc 13:488-492
376. Lucas SW, Spitz JD, Arregui ME 1999 The use of intraoperative ultrasound in laparoscopic adrenal surgery: the Saint Vincent experience. Surg Endosc 13:1093-1098
377. Henry JF, Defechereux T, Raffaelli M, Lubrano D, Gramatica L 2000 Complications of laparoscopic adrenalectomy: results of 169 consecutive procedures. World J Surg 24:1342-1346
378. Lezoche E, Guerrieri M, Paganini AM, Feliciotti F, Zenobi P, Antognini F, Mantero F 2000 Laparoscopic adrenalectomy by the anterior transperitoneal approach: results of 108 operations in unselected cases. Surg Endosc 14:920-925
379. Ishikawa T, Inaba M, Nishiguchi Y, Ishibashi R, Ogisawa K, Yukimoto K, Ogawa Y, Onoda N, Hirakawa K, Chung YS 2000 Laparoscopic adrenalectomy for benign adrenal tumors. Biomed Pharmacother 54(Suppl 1):183s-186s
380. Guazzoni G, Cestari A, Montorsi F, Lanzi R, Nava L, Centemero A, Rigatti P 2001 Eight-year experience with transperitoneal laparoscopic adrenal surgery. J Urol 166:820-824
381. Pisanu A, Jafari M, Pattou F, Carnaille B, Proye C 2001 Indications for adrenalectomy in the laparoscopic era. G Chir 22:101-106
382. Porpiglia F, Garrone C, Giraudo G, Destefanis P, Fontana D, Morino M 2001 Transperitoneal laparoscopic adrenalectomy: experience in 72 procedures. J Endourol 15:275-279
383. Valeri A, Borrelli A, Presenti L, Lucchese M, Manca G, Bergamini C, Reddavide S, Borrelli D 2001 Laparoscopic adrenalectomy. Personal experience in 78 patients. G Chir 22:185-189
384. Takeda M, Go H, Watanabe R, Kurumada S, Obara K, Takahashi E, Komeyama T, Imai T, Takahashi K 1997 Retroperitoneal laparoscopic adrenalectomy for functioning adrenal tumors: comparison with conventional transperitoneal laparoscopic adrenalectomy. J Urol 157:19-23
385. Gasman D, Droupy S, Koutani A, Salomon L, Antiphon P, Chassagnon J, Chopin DK, Abbou CC 1998 Laparoscopic adrenalectomy: the retroperitoneal approach. J Urol 159:1816-1820
386. Baba S, Ito K, Yanaihara H, Nagata H, Murai M, Iwamura M 1999 Retroperitoneoscopic adrenalectomy by a lumbodorsal approach: clinical experience with solo surgery. World J Urol 17:54-58
387. Fazeli-Matin S, Gill IS, Hsu TH, Sung GT, Novick AC 1999 Laparoscopic renal and adrenal surgery in obese patients: comparison to open surgery. J Urol 162:665-669
388. Lee WC, Hsieh HH 2000 Retroperitoneoscopic adrenalectomy: experience with thirty cases. Formosan J Surg 33:3-7
389. Subramaniam R, Pandit B, Sadhasivam S, Sridevi KB, Kaul HL 2000 Retroperitoneoscopic excision of phaeochromocytoma-haemodynamic events, complications and outcome. Anaesth Intensive Care 28:49-53
390. Tanaka M, Tokuda N, Koga H, Kimoto Y, Naito S 2000 Laparoscopic adrenalectomy for pheochromocytoma: comparison with open adrenalectomy and comparison of laparoscopic surgery for pheochromocytoma versus other adrenal tumors. J Endourol 14: 427-431
391. Bonjer HJ, Sorm V, Berends FJ, Kazemier G, Steyerberg EW, de Herder WW, Bruining HA 2000 Endoscopic retroperitoneal adrenalectomy: lessons learned from 111 consecutive cases. Ann Surg 232:796-803
392. Salomon L, Soulie M, Mouly P, Saint F, Cicco A, Olsson E, Hoznek A, Antiphon P, Chopin D, Plante P, Abbou CC 2001 Experience with retroperitoneal laparoscopic adrenalectomy in 115 procedures. J Urol 166:38-41
393. Walz MK, Peitgen K, Walz MV, Hoermann R, Saller B, Giebler RM, Jockenhovel F, Philipp T, Broelsch CE, Eigler FW, Mann K 2001 Posterior retroperitoneoscopic adrenalectomy: lessons learned within five years. World J Surg 25:728-734
394. Aldrighetti L, Giacomelli M, Calori G, Paganelli M, Ferla G 1997 Impact of minimally invasive surgery on adrenalectomy for incidental tumors: comparison with laparotomic technique. Int Surg 82:160-164
395. Bonjer HJ, Lange JF, Kazemier G, de Herder WW, Steyerberg EW, Bruining HA 1997 Comparison of three techniques for adrenalectomy. Br J Surg 84:679-682
396. Bonjer HJ, van der Harst E, Steyerberg EW, de Herder WW, Kazemier G, Mohammedamin RS, Bruining HA 1998 Retroperitoneal adrenalectomy: open or endoscopic? World J Surg 22:1246-1249
397. Brunt LM, Doherty GM, Norton JA, Soper NJ, Quasebarth MA, Moley JF 1996 Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms. J Am Coll Surg 183: 1-10
398. Dudley NE, Harrison BJ 1999 Comparison of open posterior versus transperitoneal laparoscopic adrenalectomy. Br J Surg 86:656-660
399. Hobart MG, Gill IS, Schweizer D, Bravo EL 1999 Financial analysis of needlescopic versus open adrenalectomy. J Urol 162:1264-1267
400. Hobart MG, Gill IS, Schweizer D, Sung GT, Bravo EL 2000 Laparoscopic adrenalectomy for large-volume (> or = 5 cm) adrenal masses. J Endourol 14:149-154
401. Imai T, Kikumori T, Ohiwa M, Mase T, Funahashi H 1999 A case-controlled study of laparoscopic compared with open lateral adrenalectomy. Am J Surg 178:50-53; discussion 54
402. Inabnet WB, Pitre J, Bernard D, Chapuis Y 2000 Comparison of the hemodynamic parameters of open and laparoscopic adrenalectomy for pheochromocytoma. World J Surg 24:574-578
403. Ishikawa T, Sowa M, Nagayama M, Nishiguchi Y, Yoshikawa K 1997 Laparoscopic adrenalectomy: comparison with the conventional approach. Surg Laparosc Endosc 7:275-280
404. Jacobs JK, Goldstein RE, Geer RJ 1997 Laparoscopic adrenalectomy. A new standard of care. Ann Surg 225:495-501; discussion 501-502
405. Korman JE, Ho T, Hiatt JR, Phillips EH 1997 Comparison of laparoscopic and open adrenalectomy. Am Surg 63:908-912
406. Linos DA, Stylopoulos N, Boukis M, Souvatzoglou A, Raptis S, Papadimitriou J 1997 Anterior, posterior, or laparoscopic approach for the management of adrenal diseases? Am J Surg 173:120-125
407. MacGillivray DC, Shichman SJ, Ferrer FA, Malchoff CD 1996 A comparison of open vs. laparoscopic adrenalectomy. Surg Endosc 10:987-990
408. Mugiya S, Suzuki K, Masuda H, Ushiyama T, Hata M, Fujita K 1996 Laparoscopic adrenalectomy for nonfunctioning adrenal tumors. J Endourol 10:539-541; discussion 541-543
409. Prinz RA 1995 A comparison of laparoscopic and open adrenalectomies. Arch Surg 130:489-492; discussion 492-494
410. Rayan SS, Hodin RA 2000 Short-stay laparoscopic adrenalectomy. Surg Endosc 14:568-572
411. Schell SR, Talamini MA, Udelsman R 1999 Laparoscopic adrenalectomy for nonmalignant disease: improved safety, morbidity, and cost-effectiveness. Surg Endosc 13:30-34
412. Shen WT, Lim RC, Siperstein AE, Clark OH, Schecter WP, Hunt TK, Horn JK, Duh QY 1999 Laparoscopic vs. open adrenalectomy for the treatment of primary hyperaldosteronism. Arch Surg 134: 628-631; discussion 631-632
413. Soares Jr RL, Monchik J, Migliori SJ, Amaral JF 1999 Laparoscopic adrenalectomy for benign adrenal neoplasms. Surg Endosc 13: 40-42
414. Sprung J, O'Hara Jr JF, Gill IS, Abdelmalak B, Sarnaik A, Bravo EL 2000 Anesthetic aspects of laparoscopic and open adrenalectomy for pheochromocytoma. Urology 55:339-343
415. Staren ED, Prinz RA 1996 Adrenalectomy in the era of laparoscopy. Surgery 120:706-709; discussion 710-711
416. Thompson GB, Grant CS, van Heerden JA, Schlinkert RT, Young Jr WF, Farley DR, Ilstrup DM 1997 Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery 122:1132-1136
417. Ting AC, Lo CY, Lo CM 1998 Posterior or laparoscopic approach for adrenalectomy. Am J Surg 175:488-490
418. Vargas HI, Kavoussi LR, Bartlett DL, Wagner JR, Venzon DJ, Fraker DL, Alexander HR, Linehan WM, Walther MM 1997 Laparoscopic adrenalectomy: a new standard of care. Urology 49:673-678
419. Winfield HN, Hamilton BD, Bravo EL, Novick AC 1998 Laparoscopic adrenalectomy: the preferred choice? A comparison to open adrenalectomy. J Urol 160:325-329
420. Yoshimura K, Yoshioka T, Miyake O, Matsumiya K, Miki T, Okuyama A 1998 Comparison of clinical outcomes of laparoscopic and conventional open adrenalectomy. J Endourol 12:555-559
421. Ortega J, Sala C, Garcia S, Lledo S 2002 Cost-effectiveness of laparoscopic vs. open adrenalectomy: small savings in an expensive process. J Laparoendosc Adv Surg Tech A 12:1-5
422. Duh QY, Siperstein AE, Clark OH, Schecter WP, Horn JK, Harrison MR, Hunt TK, Way LW 1996 Laparoscopic adrenalectomy. Comparison of the lateral and posterior approaches. Arch Surg 131:870-875; discussion 875-876
423. Miyake O, Yoshimura K, Yoshioka T, Honda M, Kokado Y, Miki T, Okuyama A 1998 Laparoscopic adrenalectomy. Comparison of the transperitoneal and retroperitoneal approach. Eur Urol 33:303-307
424. Fernandez-Cruz L, Saenz A, Taura P, Benarroch G, Astudillo E, Sabater L 1999 Retroperitoneal approach in laparoscopic adrenalectomy: is it advantageous? Surg Endosc 13:86-90
425. Terachi T, Yoshida O, Matsuda T, Orikasa S, Chiba Y, Takahashi K, Takeda M, Higashihara E, Murai M, Baba S, Fujita K, Suzuki K, Ohshima S, Ono Y, Kumazawa J, Naito S 2000 Complications of laparoscopic and retroperitoneoscopic adrenalectomies in 370 cases in Japan: a multi-institutional study. Biomed Pharmacother 54(Suppl 1):211s-214s
426. Takeda M 2000 Laparoscopic adrenalectomy: transperitoneal vs. retroperitoneal approaches. Biomed Pharmacother 54(Suppl 1): 207s-210s
427. Suzuki K, Kageyama S, Hirano Y, Ushiyama T, Rajamahanty S, Fujita K 2001 Comparison of 3 surgical approaches to laparoscopic adrenalectomy: a nonrandomized, background matched analysis. J Urol 166:437-443
428. Henry JF, Defechereux T, Gramatica L, Raffaelli M 1999 Should laparoscopic approach be proposed for large and/or potentially malignant adrenal tumors? Langenbecks Arch Surg 384:366-369
429. Naya Y, Nagata M, Ichikawa T, Amakasu M, Omura M, Nishikawa T, Yamaguchi K, Ito H 2002 Laparoscopic adrenalectomy: comparison of transperitoneal and retroperitoneal approaches. BJU Int 90:199-204
430. MacGillivray DC, Whalen GF, Malchoff CD, Oppenheim DS, Shichman SJ 2002 Laparoscopic resection of large adrenal tumors. Ann Surg Oncol 9:480-485
431. Hallfeldt KK, Mussack T, Trupka A, Hohenbleicher F, Schmidbauer S 2003 Laparoscopic lateral adrenalectomy versus open posterior adrenalectomy for the treatment of benign adrenal tumors. Surg Endosc 17:264-267
432. Barreca M, Presenti L, Renzi C, Cavallaro G, Borrelli A, Stipa F, Valeri A 2003 Expectations and outcomes when moving from open to laparoscopic adrenalectomy: multivariate analysis. World J Surg 27:223-228
433. Kebebew E, Siperstein AE, Clark OH, Duh QY 2002 Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Arch Surg 137:948-953
434. Sarela AI, Murphy I, Coit DG, Conlon KC 2003 Metastasis to the adrenal gland: the emerging role of laparoscopic surgery. Ann Surg Oncol 10:1191-1196
435. Kercher KW, Park A, Matthews BD, Rolband G, Sing RF, Heniford BT 2002 Laparoscopic adrenalectomy for pheochromocytoma. Surg Endosc 16:100-102
436. Gotoh M, Ono Y, Hattori R, Kinukawa T, Ohshima S 2002 Laparoscopic adrenalectomy for pheochromocytoma: morbidity compared with adrenalectomy for tumors of other pathology. J Endourol 16:245-249; discussion 249-250
437. Kopf D, Goretzki PE, Lehnert H 2001 Clinical management of malignant adrenal tumors. J Cancer Res Clin Oncol 127:143-155
438. Pommier RF, Vetto JT, Billingsly K, Woltering EA, Brennan MF 1993 Comparison of adrenal and extraadrenal pheochromocytomas. Surgery 114:1160-1165; discussion 1165-1166
439. Bravo EL 2001 Medical management of primary hyperaldosteronism. Curr Hypertens Rep 3:406-409
440. Emral R, Uysal AR, Asik M, Gullu S, Corapcioglu D, Tonyukuk V, Erdogan G 2003 Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocr J 50:399-408
441. Barnett Jr CC, Varma DG, El-Naggar AK, Dackiw AP, Porter GA, Pearson AS, Kudelka AP, Gagel RF, Evans DB, Lee JE 2000 Limitations of size as a criterion in the evaluation of adrenal tumors. Surgery 128:973-982; discussion 982-983
442. Favia G, Lumachi F, Basso S, D'Amico DF 2000 Management of incidentally discovered adrenal masses and risk of malignancy. Surgery 128:918-924
443. Bodie B, Novick AC, Pontes JE, Straffon RA, Montie JE, Babiak T, Sheeler L, Schumacher P 1989 The Cleveland Clinic experience with adrenal cortical carcinoma. J Urol 141:257-260
444. Sullivan M, Boileau M, Hodges CV 1978 Adrenal cortical carcinoma. J Urol 120:660-665
445. King DR, Lack EE 1979 Adrenal cortical carcinoma: a clinical and pathologic study of 49 cases. Cancer 44:239-244
446. Lefevre WC, Gerard-Marchant R, Gubler JP, Chaussain JL, Lemerle J 1983 Adrenal cortical carcinoma in children: 42 patients treated from 1958 to 1980 at Villejuif. In: Humphrey G, ed. Adrenal and endocrine tumors in children. Boston: Nijhoff
447. Watson RG, van Heerden JA, Northcutt RC, Grant CS, Ilstrup DM 1986 Results of adrenal surgery for Cushing's syndrome: 10 years' experience. World J Surg 10:531-538
448. Ribeiro RC, Sandrini Neto RS, Schell MJ, Lacerda L, Sambaio GA, Cat I 1990 Adrenocortical carcinoma in children: a study of 40 cases. J Clin Oncol 8:67-74
449. Sabbaga CC, Avilla SG, Schulz C, Garbers JC, Blucher D 1993 Adrenocortical carcinoma in children: clinical aspects and prognosis. J Pediatr Surg 28:841-843
450. Zografos GC, Driscoll DL, Karakousis CP, Huben RP 1994 Adrenal adenocarcinoma: a review of 53 cases. J Surg Oncol 55:160-164
451. Lee JE, Berger DH, el-Naggar AK, Hickey RC, Vassilopoulou-Sellin R, Gagel RF, Burgess MA, Evans DB 1995 Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery 118:1090-1098
452. Evans HL, Vassilopoulou-Sellin R 1996 Adrenal cortical neoplasms. A study of 56 cases. Am J Clin Pathol 105:76-86
453. Sandrini R, Ribeiro RC, DeLacerda L 1997 Childhood adrenocortical tumors. J Clin Endocrinol Metab 82:2027-2031
454. Michalkiewicz EL, Sandrini R, Bugg MF, Cristofani L, Caran E, Cardoso AM, de Lacerda L, Ribeiro RC 1997 Clinical characteristics of small functioning adrenocortical tumors in children. Med Pediatr Oncol 28:175-178
455. Khorram-Manesh A, Ahlman H, Jansson S, Wangberg B, Nilsson O, Jakobsson CE, Eliasson B, Lindstedt S, Tisell LE 1998 Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up. World J Surg 22:605-611; discussion 611-612
456. Teinturier C, Pauchard MS, Brugieres L, Landais P, Chaussain JL, Bougneres PF 1999 Clinical and prognostic aspects of adrenocortical neoplasms in childhood. Med Pediatr Oncol 32:106-111
457. Harrison LE, Gaudin PB, Brennan MF 1999 Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg 134:181-185
458. Kendrick ML, Lloyd R, Erickson L, Farley DR, Grant CS, Thompson GB, Rowland C, Young Jr WF, van Heerden JA 2001 Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 136:543-549
459. Porte H, Siat J, Guibert B, Lepimpec-Barthes F, Jancovici R, Bernard A, Foucart A, Wurtz A 2001 Resection of adrenal metastases from non-small cell lung cancer: a multicenter study. Ann Thorac Surg 71:981-985
460. Paul CA, Virgo KS, Wade TP, Audisio RA, Johnson FE 2000 Adrenalectomy for isolated adrenal metastases from non-adrenal cancer. Int J Oncol 17:181-187
461. Beitler AL, Urschel JD, Velagapudi SR, Takita H 1998 Surgical management of adrenal metastases from lung cancer. J Surg Oncol 69:54-57
462. Kim SH, Brennan MF, Russo P, Burt ME, Coit DG 1998 The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 82:389-394
463. Siren J, Tervahartiala P, Sivula A, Haapiainen R 2000 Natural course of adrenal incidentalomas: seven-year follow-up study. World J Surg 24:579-582
464. Kologlu S, Akyar S, Baskal N, Berk U 1988 Asymptomatic-non-functional adrenal masses detected by CT. Endocrinologie 26:173-178
465. Reincke M, Winkelmann W, Jaursch-Hancke C, Kaulen D, Nieke J, Ollenschlager G, Allolio B 1989 [Diagnosis and therapy of asymptomatic adrenal tumors]. Dtsch Med Wochenschr 114:861-865
466. Grossrubatscher E, Vignati F, Possa M, Lohi P 2001 The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation. J Endocrinol Invest 24:846-855
467. Libe R, Dall'Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B 2002 Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 147:489-494
468. Chuman Y, Zhan Z, Fojo T 2000 Construction of gene therapy vectors targeting adrenocortical cells: enhancement of activity and specificity with agents modulating the cyclic adenosine 3′,5′-monophosphate pathway. J Clin Endocrinol Metab 85:253-262
469. Tajima T, Okada T, Ma XM, Ramsey W, Bornstein S, Aguilera G 1999 Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochrome P450 21-hydroxylase into the adrenal gland of 21-hydroxylase- deficient mice. Gene Ther 6:1898-1903
470. Wolkersdorfer GW, Bornstein SR, Higginbotham JN, Hiroi N, Vaquero JJ, Green MV, Blaese RM, Aguilera G, Chrousos GP, Ramsey WJ 2002 A novel approach using transcomplementing adenoviral vectors for gene therapy of adrenocortical cancer. Horm Metab Res 34:279-287
471. Bornstein SR, Webster EL, Torpy DJ, Richman SJ, Mitsiades N, Igel M, Lewis DB, Rice KC, Joost HG, Tsokos M, Chrousos GP 1998 Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. Endocrinology 139:1546-1555
472. Willenberg HS, Bornstein SR, Hiroi N, Path G, Goretzki PE, Scherbaum WA, Chrousos GP 2000 Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function. Mol Psychiatry 5:137-141
473. Bornstein SR, Gonzalez-Hernandez JA, Ehrhart-Bornstein M, Adler G, Scherbaum WA 1994 Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab 78:225-232
474. Willenberg HS, Stratakis CA, Marx C, Ehrhart-Bornstein M, Chrousos GP, Bornstein SR 1998 Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome. N Engl J Med 339:27-31